Invesco Biotechnology & Genome ETF
PBE
PBE
94 hedge funds and large institutions have $83.9M invested in Invesco Biotechnology & Genome ETF in 2025 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 31 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
48% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 31
Holders
94
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.29M | |
| 2 | +$1.1M | |
| 3 | +$873K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$452K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
+$396K |
Top Sellers
| 1 | -$697K | |
| 2 | -$621K | |
| 3 | -$593K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$569K |
| 5 |
GM
GeoWealth Management
Chicago,
Illinois
|
-$460K |
